Wilson Sonsini Goodrich & Rosati advised Foresight Diagnostics on the transaction. Allogene Therapeutics Inc. (Nasdaq: ALLO) and Foresight Diagnostics, announced a strategic partnership to develop a minimal residual…
Foresight Diagnostics’ Partnership with Allogene Therapeutics
![](https://globallegalchronicle.com/wp-content/uploads/2024/01/foresight-diagnostics-partnership-with-allogene-therapeutics_65b21aa1a871f.jpeg)